Skip to content

Cumberland Pharmaceuticals Inc

CPIX· NasdaqCore metricsCIK 1087294

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · +3.87%
Market cap
$98.52M
15M shares
Filings
1,012
$2.16M
Q3 2026+17.6% FY25 yoy
$77.78M
Q3 2026N/M FY25 yoy
-$1.94M
Q3 2026N/M FY25 yoy
-$990.35K
Q3 2026derivedN/M FY25 yoy
$5.07
Q3 2026N/M FY25 yoy
$80.58M
Q3 2026−36.3% FY24 yoy
$98.52M
1.4×
2.9×
1.4×
-1.00%
—

Twelve months to Sep 30, 2026 · derived

Price

$6.57+222.06%+$4.53past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$44.52MFY 2025
$44.52M0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$44,521,431reported
FY 20242024-12-31$37,867,945reported
FY 20232023-12-31$39,552,507reported
FY 20222022-12-31$42,010,949 revisedreported
FY 20212021-12-31$35,045,259reported
FY 20202020-12-31$35,840,673reported
FY 20192019-12-31$32,407,845 revisedreported
FY 20182018-12-31$28,803,961 revisedreported
FY 20172017-12-31$40,376,563 revisedreported
FY 20162016-12-31$32,478,185 revisedreported
FY 20152015-12-31$900,000reported
FY 20142014-12-31$600,000reported

Capital returns

Dividends and buybacks · FY2016 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$263.48K$263.48K—14.96M sh±0.0%5.4%
FY2024—$579.05K$579.05K—14.96M sh+5.5%—
FY2023—$740.53K$740.53K—14.18M sh−1.5%12.7%
FY2022—$1.05M$1.05M—14.40M sh−3.0%12.6%
FY2021—$1.39M$1.39M—14.84M sh−0.5%22.2%

Segments

Products
Revenue by Products, FY2018 to FY2025FY2018Vibativ · FY2018 · $5.08MOther · FY2018 · $23.73MFY2019Vibativ · FY2019 · $8.69MOther · FY2019 · $23.72MFY2020Vibativ · FY2020 · $10.87MOther · FY2020 · $24.97MFY2021Vibativ · FY2021 · $11.70MOther · FY2021 · $23.34MFY2022Sancuso · FY2022 · $13.21MKristalose · FY2022 · $15.21MVibativ · FY2022 · $7.49MCaldolor · FY2022 · $4.83MOther · FY2022 · $1.33MOther · FY2022 · $33.12MFY2023Sancuso · FY2023 · $8.10MKristalose · FY2023 · $15.98MVibativ · FY2023 · $8.81MCaldolor · FY2023 · $4.33MOther · FY2023 · $2.04MOther · FY2023 · $288.24KFY2024Sancuso · FY2024 · $9.01MKristalose · FY2024 · $15.32MVibativ · FY2024 · $7.16MCaldolor · FY2024 · $4.96MOther · FY2024 · $1.33MProduct - Other · FY2024 · $1.33MOther · FY2024 · $97.81KFY2025Sancuso · FY2025 · $11.91MKristalose · FY2025 · $10.54MVibativ · FY2025 · $9.48MCaldolor · FY2025 · $4.66MOther · FY2025 · $4.13MProduct - Other · FY2025 · $4.13MProduct - Talicia · FY2025 · $3.31MOther · FY2025 · $490.78K
LineFY2025ShareChange
Sancuso$11.91M27%+32.2%
Kristalose$10.54M24%−31.2%
Vibativ$9.48M21%+32.5%
Caldolor$4.66M10%−6.0%
Other$4.13M9.3%+210.1%
Product - Other$4.13M9.3%+210.1%
Product - Talicia$3.31M7.4%—
Other$490.78K1.1%+401.8%
Total$44.52M

From the 10-K filed Mar 9, 2026CPIX

Pharmaceutical preparations

Cumberland Pharmaceuticals Inc is the 133rd largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Cumberland Pharmaceuticals Inc · CIK 1087294 · Engraved from SEC EDGAR